We and others previously demonstrated that activation of the cholinergic nervous system through the administration of specific acetylcholinesterase inhibitors (AChEI) attenuates the development of hyperglycemia and experimental diabetes (36, 37). This evidence concerns the gene ACHE and Hyperglycemia.